Total Voting Rights

RNS Number : 1839C
Open Orphan PLC
06 February 2020
 

6 February 2020

 

Open Orphan plc

("Open Orphan", the "Company" or the "Group")

Total voting rights

 

In conformity with the FCA's Disclosure Guidance and Transparency Rules, following Admission of the Placing and Subscription Shares, the Company confirms that as at the time of this announcement, its issued share capital consists of 532,507,581 ordinary shares of 0.1 pence each ("Ordinary Shares"). All of the Ordinary Shares have equal voting rights and there are no Ordinary Shares held in treasury. This figure of 532,507,581 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

Capitalised terms in this announcement shall have the same meanings given to such terms in the Group's announcement at 7.00 a.m. on 31 January 2020.

 

For further enquiries, please contact:

 

Open Orphan plc                                                                                                            

Cathal Friel, Executive Chairman                                                                         +353 (0)1 644 0007

Trevor Phillips, Chief Executive Officer                                                               +44 (0)20 7347 5350

 

Arden Partners plc (Nominated Adviser and Joint Broker)                           +44 (0)20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer

 

Davy (Euronext Growth Adviser and Joint Broker)                                         +353 (0)1 679 6363

Anthony Farrell

 

Camarco (Financial PR)                                                                                          +44 (0)20 3757 4980

Tom Huddart / Daniel Sherwen

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRFIFETFTIRIII

Companies

Hvivo (HVO)
UK 100

Latest directors dealings